Citigroup Inc Celldex Therapeutics, Inc. Call Options Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$32.06 - $44.56 $981,036 - $1.36 Million	30,600 New	30,600 $1.04 Million
Q3 2022 Nov 10, 2022	SELL	$22.7 - $37.57 $2.5 Million - $4.13 Million	-110,000 Reduced 91.67%	10,000 $281,000
Q2 2022 Aug 10, 2022	SELL	$20.5 - $37.33 $1.23 Million - $2.24 Million	-60,000 Reduced 33.33%	120,000 $3.24 Million
Q4 2021 Feb 10, 2022	BUY	$35.68 - $56.27 $6.42 Million - $10.1 Million	180,000 New	180,000 $6.96 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.